Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

96 results about "Tumor removal" patented technology

Definition. Tumor removal is a surgical procedure to remove an abnormal growth. A tumor can be either benign, like a wart, or malignant, in which case it is a cancer. Benign tumors are well circumscribed and generally are easy to remove completely. Currently 40% of all cancers are treated with surgery alone.

Tumor electric field treatment device and treatment system

The utility model discloses a tumor electric field treatment device and a treatment system, the tumor electric field treatment device is provided with a frame body and a pole piece module, the frame body forms a skeleton structure of the treatment device, the pole piece module is attached to the frame body, the pole piece module is provided with a plurality of electrode contacts, and each electrode contact can form an active contact or a passive contact. The active contact and the radio frequency generation module can form a loop; after the treatment device is implanted into a tumor excision part, all the electrode contacts form active contacts, and all the electrode contacts and the radio frequency generation module form a loop to distinguish normal tissues from pathological tissues; after the normal tissue and the lesion tissue are distinguished, the electrode contacts in the normal tissue area form passive contacts, and the electrode contacts in the lesion tissue area form active contacts, so that targeted treatment of the lesion tissue is realized, and side effects generated by electric field treatment are reduced.
Owner:WUHAN NEURACOM TECH DEV CO LTD

Navigation system for liver tumor resection surgery

The invention discloses a navigation system for a liver tumor resection operation, and aims to solve the problems that in the prior art, the accuracy of the liver tumor resection operation is insufficient, the risk in the operation is high, and the evaluation after the operation is incomplete. The system comprises a preoperative data acquisition module, a preoperative three-dimensional modeling module, an intraoperative positioning module, an operation navigation module, a risk prompt module and a postoperative data analysis module. Through preoperative CT or MRI image data acquisition, automatic segmentation and three-dimensional reconstruction of liver, tumor and blood vessels are carried out by using a deep learning algorithm, and a high-precision anatomical model is generated. During the operation, the position of the surgical instrument is obtained in real time by using an optical tracking or electromagnetic positioning technology, spatial precise alignment of the surgical instrument with a tumor and surrounding tissues is realized in combination with a model registration algorithm, and a surgical path is displayed through a real-time navigation interface. And the risk prompting module calculates an excision risk coefficient and prompts a doctor in real time based on the shortest distance between the tumor and the blood vessel, the relative distance between the instrument and the target area and the trajectory change.
Owner:HANGZHOU FIRST PEOPLES HOSPITAL

Tumor electric field treatment device, treatment system and manufacturing method of treatment device

The invention discloses a tumor electric field treatment device and system, the tumor electric field treatment device is provided with a frame body and a pole piece module, the frame body forms a skeleton structure of the treatment device, the pole piece module is attached to the frame body, the pole piece module is provided with a plurality of electrode contacts, and each electrode contact can form an active electric contact or a passive electric contact. The active electric contact and the radio frequency generation module can form a loop; after the treatment device is implanted into a tumor excision part, all the electrode contacts form active electric contacts, and all the electrode contacts and the radio frequency generation module form a loop to distinguish normal tissues from pathological tissues; after the normal tissue and the lesion tissue are distinguished, the electrode contacts in the normal tissue area form passive electric contacts, and the electrode contacts in the lesion tissue area form active electric contacts, so that targeted treatment of the lesion tissue is realized, and side effects generated by electric field treatment are reduced.
Owner:WUHAN NEURACOM TECH DEV CO LTD

Double-targeting near-infrared fluorescent probe for estrogen receptor alpha and fibroblast activating protein as well as preparation method and medical application of double-targeting near-infrared fluorescent probe

The invention relates to an estrogen receptor alpha and fibroblast activating protein dual-targeting near-infrared fluorescent probe as well as a preparation method and medical application thereof. Specifically, the probe can be used as a fluorescence probe for developing cells co-expressing the estrogen receptor alpha and the fibroblast activating protein, and can also be used as a near-infrared fluorescence imaging probe for diagnosing benign / malignant lesions such as nodules / tumors co-expressing the estrogen receptor alpha and the fibroblast activating protein. The fluorescent probe can also be applied to research on related biological events in cells for co-expressing the estrogen receptor alpha and the fibroblast activating protein, and particularly can be applied to fluorescent navigation in tumor resection operations for co-expressing the estrogen receptor alpha and the fibroblast activating protein; particularly, the composition can be applied to the synergistic treatment of an anti-estrogen therapy and a photodynamic therapy on a diseased region which co-expresses the estrogen receptor alpha and the fibroblast activating protein.
Owner:NANJING MEDICAL UNIV

A near-infrared second-zone small molecule optical diagnostic and therapeutic reagent based on hydrogen sulfide activation, and its preparation method and application

The present invention provides a hydrogen sulfide-activated near-infrared II small molecule optical diagnostic and therapeutic agent, whose chemical structure is: [Illegible text - likely a missing link]. This diagnostic and therapeutic agent can accurately identify solid tumors overexpressing hydrogen sulfide, effectively distinguishing tumors from normal tissue, and can be used for tumor resection under the guidance of NIR-II fluorescence imaging. Furthermore, it has excellent photothermal conversion efficiency and can successfully ablate tumors under laser irradiation. This agent demonstrates significant advantages in tumor identification and treatment and is expected to become a highly effective molecular tool for tumor diagnosis and treatment.
Owner:THE SECOND PEOPLES HOSPITAL OF SHANDONG PROVINCE (SHANDONG PROVINCIAL EAR NOSE & THROAT HOSPITAL SHANDONG PROVINCIAL INST OF EAR NOSE & THROAT)

Method for treatment of cholangiocarcinoma with cold atmospheric plasma and folfirinox

A method for a method for treatment of cholangiocarcinoma (CCA) with cold atmospheric plasma and Folfirinox. The method includes treating a patient having CCA with a low dosage FOLFIRINOX regimen, for example, 6.73 nM, giving the patient the low-dosage FOLFIRINOX regimen pre-operatively, surgically removing the cancerous tumor from the patient, continuing the low-dosage FOLFIRINOX treatment regimen intra-operatively, applying cold atmospheric plasma to the surgical margins surrounding the area in the patient from which the tumor was removed, and continuing the FOLFIRINOX post-operatively.
Owner:JEROME CANADY RES INST FOR ADVANCED BIOLOGICAL & TECHCAL SCI

Tumor bagging and cutting device for operation

The invention relates to the technical field of tumor extraction in vitro, and particularly discloses a tumor bagging and cutting device for an operation. The tumor bagging and cutting device for the operation comprises an inner memory wire, an outer memory wire, an inner-layer bag, an outer-layer bag, a core tube, a plurality of first-direction cutting ropes and a plurality of second-direction cutting ropes. An inner ring cavity is formed in a bag opening of the inner-layer bag. The inner memory wire rod is arranged in the inner ring cavity in a penetrating mode, and the two ends of the inner memory wire rod penetrate into the core tube. An outer ring cavity is formed in a bag opening of the outer-layer bag. The outer memory wire rod is arranged in the outer ring cavity in a penetrating mode. The middle section of the first-direction cutting rope and the middle section of the second-direction cutting rope are both located in the inner-layer bag. And for the cut tumor which is still in the human body, the tumor is put into the inner-layer bag, the tumor is cut by using the first-direction cutting rope and the second-direction cutting rope, and the cut tumor is taken out after being cut into small strips. The tumor linear cutting mode is high in safety coefficient. The inner-layer bag protects the outer-layer bag, so that the chopped tumor does not leak out of the outer-layer bag, and the safety is improved.
Owner:王燕波

Doxorubicin-loaded anti-tumor hemostatic microspheres and preparation and use thereof

The present application relates to providing a doxorubicin-loaded anti-tumor hemostatic microsphere constructed by a simple, safe and low-cost method and its preparation and application, the doxorubicin-loaded anti-tumor hemostatic microsphere comprises alginate, hemostatic component A, doxorubicin or doxorubicin liposome, crosslinking agent, the hemostatic component A is selected from one or more of carboxymethyl chitosan, hyaluronic acid, collagen, silk fibroin, solve the practical pain point problems such as easy bleeding in tumor resection surgery, large toxicity of chemotherapeutic drugs, large drug dose, frequent drug administration, etc., realize rapid hemostasis in operation, postoperative precise targeted drug delivery, reduce toxic side effects, long-acting drug sustained release, at the same time, all components of the system are safe and reliable, and have good biocompatibility.
Owner:ZHEJIANG SCI-TECH UNIV

Fibroblast cell activating protein inhibitor-chlorine-containing indole heptamethine cyanine dye coupled near-infrared fluorescent probe, preparation method and medical application thereof

The invention relates to a compound as shown in a formula (I) and / or a formula (II) and / or a formula (III) or a tautomer or pharmaceutically acceptable salt thereof, a preparation method and application of the compound or the tautomer or the pharmaceutically acceptable salt in medicine. Specifically, the fluorescent probe can be used as a fluorescent probe for cytological imaging, can also be used as a near-infrared fluorescent imaging probe for diagnosing benign / malignant lesions such as fibrosis, nodules and tumors, and can also be applied to research of related biological events in cytobiology and molecular biology. The fluorescent probe can be particularly applied to fluorescent navigation in tumor resection surgery.
Owner:SUZHOU YUANJU PHARMACEUTICAL TECHNOLOGY CO LTD

Target material spraying machine spray gun capable of automatically cleaning accumulated burls

The utility model discloses a target material spraying machine spray gun capable of automatically cleaning accumulated burls, which comprises a spray gun body, an accumulated burl cleaning device and a control device, the spray gun body is provided with a gun nozzle and a powder feeding pipe, the powder feeding pipe is positioned on one side of the gun nozzle, the accumulated burl cleaning device comprises a mounting frame, a linear cylinder and an accumulated burl push rod, and the linear cylinder is connected with the control device. The mounting frame is fixedly mounted on one side of the spray gun body, the linear air cylinder is fixedly mounted on the mounting frame, the first end of the build-up push rod is fixedly connected with a piston rod of the linear air cylinder, the second end of the build-up push rod is provided with a shoveling plane used for shoveling build-up, and the build-up push rod slides front and back towards the gun nozzle and the powder feeding pipe. And cleaning gaps are respectively formed between the accumulation push rod and the gun nozzle and between the accumulation push rod and the powder feeding pipe. The accumulated tumor on the gun nozzle and the powder feeding pipe is directly shoveled through the accumulated tumor push rod moving linearly, the removing effect is improved, the accumulated tumor can be thoroughly removed by moving the accumulated tumor push rod back and forth once, repeated moving for removing is not needed, the accumulated tumor removing efficiency is improved, and the production efficiency is improved.
Owner:OMAT SPUTTERING TARGETS DONGGUAN CO LTD +1

Gynecological tumor removal operating forceps

The invention relates to the technical field of operating forceps, and discloses gynecological tumor removal operating forceps which comprise an outer rod, an inner rod movably connected to the interior of the outer rod, a first handle fixedly connected to the outer end of the inner rod and a connecting assembly arranged between the outer rod and the inner rod. A limiting mechanism is arranged between the first handle and the inner rod, the top end of the first spring is fixedly connected with the second clamping rod, the outer side of the positioning block is fixedly connected with the mounting base, the slope clamping block movably penetrates through the movable groove and is clamped with the clamping groove, one end of the second spring is fixedly connected with the movable block, and a movable hole is formed in the outer side of the inner wall of the movable groove. And a pull rod is movably connected into the movable hole. The problems that when an existing device is used, a clamping rod is inconvenient to replace, and after the clamping rod is damaged and deforms, the whole operating forceps are scrapped, so that resource loss is caused are solved.
Owner:NINGBO WOMEN & CHILDRENS HOSPITAL

An endoscopic foreign body and tumor body extraction device

The application belongs to the technical field of medical auxiliary devices, and is especially an endoscopic foreign body and tumor removal device, which comprises a gastroscope tube, an outer protective tube and a clamping tube. The outer protective tube is sleeved on the outside of the gastroscope tube, and the clamping tube is arranged in the inside of the gastroscope tube. The rear end of the clamping tube is fixedly connected with a control handle. The inside of the control handle is screw-connected with a T-shaped screw rod. The front end of the control handle is connected with a sliding block through a rotating shaft, and the sliding block is slidingly connected with the control handle. The front end of the sliding block is fixedly connected with a main control line, and the front end of the main control line extends to the inside of the front end of the clamping tube. The front end of the main control line is connected with a branch line one and a branch line two respectively. The application can clamp foreign bodies or circular pathological tissues, and the foreign bodies or circular pathological tissues can be covered by the semicircular clamping sleeve one and the semicircular clamping sleeve two, so that the foreign bodies or circular pathological tissues are not easy to fall off during the clamping and removal process, and the application is better.
Owner:雅安市人民医院

A bipolar radiofrequency electrode for bone tumor surgery

This utility model discloses a bipolar radiofrequency electrode for bone tumor surgery, which includes a cable assembly, a handle, a scalpel, and a scalpel head connected in sequence. The scalpel head includes a suction tube and an outer steel tube that is spaced and sleeved on the suction tube, with a water outlet channel formed between the suction tube and the outer steel tube. The scalpel head includes an insulating head fixed to the distal end of the outer steel tube. The insulating head is provided with a first strip electrode and a second strip electrode arranged side by side. The insulating head located at the first strip electrode and the second strip electrode has several suction holes, which are connected to the suction tube. Several water outlet holes connected to the water outlet channel are provided on both sides of the distal end of the outer steel tube. This solution uses radiofrequency electrodes to irrigate the incision after the resection of benign spinal tumors, which can accurately stop bleeding at soft tissue bleeding points, effectively reducing the amount of bleeding. Furthermore, by utilizing the circulating supply of physiological saline, the first strip electrode and the second strip electrode are effectively wrapped by physiological saline, thereby ensuring the plasma excitation efficiency.
Owner:TIANJIN TUMOR HOSPITAL

Medical implants for marking surgical sites

Implantable fiducial marker devices with a predefined shape can deform when stress is applied in vivo, and recover their shape when stress is removed reduce patient discomfort and palpability. The devices can be used to mold irregular tumor resection cavities into a more ideal shape for radiation therapy allowing more accurate treatment. After treatment, the devices resorb eliminating unnecessary testing that occurs when clinicians are unaware of implanted fiducial marker devices. Tissue ingrowth into the devices can also result in improved cosmetic outcomes when the devices are implanted in the breast after a lumpectomy. The devices preferably comprise poly-4-hydroxybutyrate or poly(butylene succinate) or copolymers thereof.
Owner:TEPHA INC

Methods And Systems For Surgical Navigation Using Spatial Registration Of Tissue Fluorescence During A Resection Procedure

A neurosurgical method for determining a resection status of a tumor is described. The method includes acquiring a medical image of a human organ including a segmented tumor. The method further includes determining a pose of a suction tool including at least one optical fiber and a navigation tracker. The method further includes generating excitation light for the at least one optical fiber to excite the target area which includes the tumor and a margin area surrounding the tumor. The method further includes receiving collected fluorescence emitted from the target area. The method further includes determining whether tissue in the target area corresponds to the tumor based on the collected fluorescence at the pose of the suction tool. The method further includes displaying the resection status of the target area relative to the medical image.
Owner:STRYKER EUROPEAN OPERATIONS LIMITED

Nonconductive field guide for resection cavity, and systems and methods of using same

A method for treating tumor cells around a resection cavity comprises positioning a nonconductive material within a resection cavity that is adjacent to a target region. At least a first electrode and a second electrode are positioned relative to the tumor resection cavity so that electric fields between the at least one first electrode and the at least one second electrode travel through the target region. Tumor-treating electric fields are the generated between the at least one first electrode and the at least one second electrode.
Owner:NOVOCURE GMBH

Tumor resection operation planning method and system based on 3D model and storage medium

The invention belongs to the technical field of medical image processing, and discloses a tumor resection operation planning method and system based on a 3D model, and a storage medium. The method comprises the following steps: obtaining a first medical image and a second medical image, and extracting all blood vessel branch structures in a target organ in each medical image, registering the first medical image and the second medical image based on a common branch structure, generating a third medical image, extracting a tumor area and a blood supply branch connected with the tumor, calculating the shortest distance from the center point of the tumor to the outer surface of the target organ, judging whether the shortest distance is smaller than a first preset value or not, if yes, generating a first surgical area, and if not, generating a second surgical area; and if not, generating a second surgical area, and planning a planned resection range and a surgical approach based on the surgical area. According to the technical scheme, the accuracy and the success rate of the operation can be improved.
Owner:SHAANXI CANCER HOSPITAL (SHAANXI INST OF CANCER PREVENTION & TREATMENT) (SHAANXI THIRD PEOPLES HOSPITAL)

Nonconductive Field Guide For Resection Cavity, And Systems And Methods Of Using Same

A method for treating tumor cells around a resection cavity comprises positioning a nonconductive material within a resection cavity that is adjacent to a target region. At least a first electrode and a second electrode are positioned relative to the tumor resection cavity so that electric fields between the at least one first electrode and the at least one second electrode travel through the target region. Tumor-treating electric fields are the generated between the at least one first electrode and the at least one second electrode.
Owner:NOVOCURE GMBH

Intelligent image recognition system and method in fluorescence state

The invention discloses an intelligent image recognition method in a fluorescence state, and relates to the technical field of medical equipment, and the method comprises the following steps: collecting a fluorescence image and a white light image at the same time point through 4K fluorescence endoscope camera equipment, and carrying out the image preprocessing, including illumination correction, fuzzy correction, filtering and denoising, and edge enhancement; based on a Mask RCNN algorithm, performing intelligent identification on a tumor boundary in the fluorescence image, and identifying the tumor boundary in the fluorescence image; performing spatial alignment on the fluorescent image and the white light image through an image registration technology; based on a GAN algorithm, fusing the identified tumor boundary with the white light image to generate a high-precision fused image; automatically marking a safe cutting edge in the white light image according to a preset safe cutting edge distance; and finally, displaying the marked white light image in real time to assist a doctor in tumor excision. According to the invention, the operation burden of a doctor in image switching is reduced, and the accuracy of an operation is improved.
Owner:HEFEI DVL ELECTRON CO LTD

Retrieval device and method for retrieving tissue

According to the invention, in order to remove tissue, in particular pathogenic tissue, from a body cavity of a patient, a removal device is provided having a removal bag (12) which is completely or partially composed of a hydrophilic, water-permeable filter membrane (26). The filter membrane (26) comprises a pore width of preferably less than 12 pm, further preferably less than 8 pm and in a preferred case less than 5 pm, in order to reliably avoid the passage of pathogenic cells or other pathogenic material. However, the pores are at least large enough so that water can easily exit from the removal bag (12). In this way, the removal bag (12) only needs to be occupied by the volume of the contained tissue to be removed in the filled state. The liquid provided within the removal bag (12) can be drained from the removal bag through the filter membrane (26) and thus does not increase its volume. This allows relatively large tissue masses to be accommodated during tumor removal. Thus, tumors can be removed as a whole without having to separate them within the body cavity. As a result, the risk of malignant tissue spreading and the risk of recurrence associated therewith is significantly reduced.
Owner:ERBE ELEKTROMEDIZIN GMBH

Anti-tumor electrospinning stent and preparation method thereof

The invention belongs to the technical field of medical instruments, and particularly discloses an anti-tumor electrospinning stent and a preparation method thereof. The drug-loaded electrospinning stent is characterized by comprising a drug-loaded electrospinning stent main body and tumor cell-derived drug-loaded microparticles loaded on the surface of the drug-loaded electrospinning stent main body. The drug-loaded electrospinning stent main body comprises an amino polymer, a hydrophilic polymer and celecoxib which are prepared by using an electrospinning technology and have a mass ratio of (2-10): (2-13): 1, and the drug-loaded electrospinning stent main body has high specific surface area and high porosity; the loading capacity of the tumor cell source doxorubicin-loaded microparticles on the anti-tumor electrospinning bracket is 0.6 mu g / mg to 6.1 mu g / mg. The drug is directly delivered to a tumor resection cavity in an in-situ implantation mode, and long-acting drug retention, continuous drug release and complete degradation of a stent material are achieved. The tumor immune microenvironment is remodeled while residual tumor cells are effectively killed, and recurrence and metastasis of tumors are inhibited.
Owner:HUAZHONG UNIV OF SCI & TECH

Personalized preoperative risk assessment method for spinal tumor resection surgery

The invention discloses a personalized preoperative risk assessment method for a spinal tumor resection operation, and the method comprises the steps: carrying out the standardization processing of features extracted from the case data of a patient and the corresponding operation plan data, and obtaining the processed features; the method comprises the following steps: preprocessing medical image data to obtain preprocessed data, performing tumor segmentation on the data through a three-dimensional attention U-Net network to obtain a tumor voxel-level probability graph, and calculating a tumor volume; obtaining the type of the tumor through the preprocessed data, the double-flow deep network and the type discrimination network; respectively carrying out standardization processing on the type, the tumor volume, the extracted wettability score and the tumor position grade to form a third feature; obtaining basic weights of the processed features and the third features from a historical database, and then dynamically adjusting the basic weights to obtain a target weight; and performing weighted summation on the target weight, the processed feature and the third feature to obtain a risk score, and matching the risk score with a preset risk score to obtain a preoperative risk assessment level.
Owner:CHINESE PEOPLES ARMED POLICE FORCE BEIJING CORPS HOSPITAL

Non-small cell lung cancer tissue discrimination model based on differential metabolite combination as well as construction method and application of non-small cell lung cancer tissue discrimination model

The invention belongs to the technical field of biomedicine, and particularly relates to a non-small cell lung cancer tissue discrimination model based on differential metabolite combination as well as a construction method and application of the non-small cell lung cancer tissue discrimination model. The differential metabolite combination is composed of lactic acid, phosphoethanolamine, decenoyl carnitine and symmetric dimethylarginine or composed of xanthine, phosphoethanolamine, N-acetyl aspartic acid, decenoyl carnitine and symmetric dimethylarginine, and the determination model establishment method comprises the following steps: collecting and treating a lung cancer tissue sample, carrying out UPLC-HRMS detection, carrying out compound identification, and carrying out quantitative determination. Differential metabolites are screened, key differential metabolites are selected through an LASSO method, the performance of all models based on the key differential metabolites is tested, and the selected optimal model is a logistic regression model. The logistic regression discrimination model based on four or five differential metabolites can effectively distinguish non-small cell lung cancer tumor tissues and normal tissues, and the accuracy, the sensitivity, the specificity, the F1 fraction and the AUC are all greater than 0.8. The model has a small quantity of metabolites, and shows the potential of assisting in clinical detection of non-small cell lung cancer tissues and the potential of assisting surgeons in determining a tumor excision range.
Owner:OCEAN UNIV OF CHINA

Application of timosaponin AIII in preparation of curative effect enhancer for CAR-T cell therapy and product for overcoming drug resistance

The invention discloses application of timosaponin AIII in preparation of a curative effect enhancer for CAR-T cell therapy and a product for overcoming drug resistance. The invention proves that TAIII is an allosteric inhibitor of an adenosine A2A receptor, and blocks a downstream signal channel through allosteric combination with A2AR, so that expression of a transcription factor FoxP3 is inhibited, Tregs in a CAR-T product is selectively cleared, immunosuppression of the Tregs on effector T cells is relieved, meanwhile, the proportion of central memory T cells is increased, and amplification, durability and cytokine secretion functions of the CAR-T cells are enhanced. The invention further provides a CAR-T cell composition containing the TAIII, and the TAIII and the CAR-T cells are combined or used as a pretreatment agent, so that the tumor removal capability can be remarkably enhanced, and recurrence after treatment can be effectively prevented. The invention provides a safe and effective new strategy for enhancing the anti-tumor activity of the CAR-T cells and overcoming the drug resistance of the CAR-T therapy.
Owner:SHANGHAI TONGJI HOSPITAL

Overlap removing cutter for non-standard track

The utility model relates to an overlap removing cutter for a non-standard track. The overlap removing cutter comprises a bottom cutter, a first side cutter, a top cutter and a second side cutter which are connected in sequence, the dead knife is horizontally arranged, the first side knife is connected to the upper end face of the dead knife and located on one side of the dead knife, the first side knife is fixedly connected with the dead knife, the other side of the first side knife is hinged to the top knife, and the other side of the top knife is hinged to the second side knife. The other side of the second side cutter is connected with the other side of the dead cutter through a pin shaft; and after the second side cutter is connected with the dead cutter, the dead cutter, the first side cutter, the top cutter and the second side cutter are matched together to form a surrounding type cavity surrounding the non-standard track. The utility model has the advantages that the bottom cutter, the first side cutter, the top cutter and the second side cutter are matched with one another, so that a surrounding type cavity for surrounding the non-standard rail is formed, the tumor removal operation can be carried out on four surfaces of the square steel rail only by one action, and the working efficiency is greatly improved.
Owner:SHANGHAI ZHENHUA HEAVY IND

Systems, Methods and Apparatus of Mixed Reality Tumor Resection Planning

Systems, methods and apparatus are provided through which a tumor resection planning tool in mixed reality comprises apparatuses for image registration, synchronous navigation through fused datasets, segmentation and labeling of surgery-related structures, manual correction of segmentation results, and a browser-based tool for clinical validation. In some implementations the tumor resection planning tool generates a step-by-step surgical tumor resection plan adaptable to organs such as liver, pancreas, lung, and brain. In some implementation the tumor resection planning tool displays segmented structures as 3D polygonal objects with customizable textures, transparency, and color. Risk margins offset from tumor surfaces are visualized with user-defined values. In some implementations vessel clip plan tool(s) simulate post-resection blood flow. Users can create, modify, and share resection plans, dividing organ structures based on user-defined plans. In some implementations vessel clip plan tool(s) enables a mixed reality shared experience for remote discussion of surgery plans among tumor board members.
Owner:APOQLAR GMBH

Methods for analyzing low-depth genome sequencing data to detect minimal residual disease

Methods and systems for determining recurrence of a tumor in a subject using mutational profiles derived from cell-free DNA obtained concurrently with or prior to tumor resection and integrating mutational profiles from the resected tumor to enhance classification models. Low-depth whole-genome sequencing data can be used to obtain a variety of molecular profiles, including genetic and epigenetic profiles, from tumor tissue and blood samples obtained after the tumor is resected from the subject. The methods may also comprise using a classifier trained to recognize mutational profiles from subjects exhibiting minimal residual disease (MRD) to determine whether a tumor recurred in a subject.
Owner:GUARDANT HEALTH INC

Glioma operation boundary identification marker and application thereof

The invention discloses a glioma operation boundary identification marker and application thereof. The invention confirms that SERPINA3 can be used as a marker for identifying a glioma invasion boundary for the first time, can effectively assist operation planning and tumor excision before or during glioma operation, improves the accuracy of operation excision, provides an effective molecular tool for clinical diagnosis and treatment of glioma, and has a remarkable application prospect.
Owner:CENT SOUTH UNIV